Sunderland Julie 4
4 · Compass Therapeutics, Inc. · Filed Jun 23, 2020
Insider Transaction Report
Form 4
Sunderland Julie
Director
Transactions
- Purchase
Common Stock
2020-06-19$5.00/sh+289,118$1,445,590→ 2,502,025 total(indirect: See Footnote)
Footnotes (1)
- [F1]These shares are held directly by Biomatics Capital Partners, LP. The Reporting Person is a member of the Issuer's board of directors, the co-founder of and a managing partner at Biomatics Capital Partners, and exercises shared voting and investment power of the securities held by Biomatics Capital Partners, LP.